
Interaction between rosuvastatin and lopinavir/r: rosuvastatin levels increased by 150-200%
HIV Treat Bull - Vol. 7, No. 5, May 2006
In the drug interaction table on page 20 of the April edition of HTB (Volume 7, Number 4), we indicated that rosuvastatin levels were decreased, when in fact they are increased by 150-200%. In addition, the comment on page 18 only mentioned “interaction was unexpected” without indicating that this produced higher levels.
We apologise for this error and any inconvenience caused.
This has now been corrected on the web edition.
Other websites providing online coverage from the meeting are listed in the On The Web section of HTB.
2008-03-10
IB060705-02
©2008. I-BASE HIV Treatment Bulletin. Permission to reproduce courtesy of HIV i-Base, Third Floor East, Thrale House, 44-46 Southwark Street, London SE1 1UN - T: +44 (0) 20 7407 8488 F: +44 (0) 20 7407 8489
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.